Latacz, G.; Sałat, K.; Furgała-Wojas, A.; Martyniak, A.; Olejarz-Maciej, A.; Honkisz-Orzechowska, E.; Szymańska, E.
Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies. Molecules 2022, 27, 875.
https://doi.org/10.3390/molecules27030875
AMA Style
Latacz G, Sałat K, Furgała-Wojas A, Martyniak A, Olejarz-Maciej A, Honkisz-Orzechowska E, Szymańska E.
Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies. Molecules. 2022; 27(3):875.
https://doi.org/10.3390/molecules27030875
Chicago/Turabian Style
Latacz, Gniewomir, Kinga Sałat, Anna Furgała-Wojas, Adrian Martyniak, Agnieszka Olejarz-Maciej, Ewelina Honkisz-Orzechowska, and Ewa Szymańska.
2022. "Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies" Molecules 27, no. 3: 875.
https://doi.org/10.3390/molecules27030875
APA Style
Latacz, G., Sałat, K., Furgała-Wojas, A., Martyniak, A., Olejarz-Maciej, A., Honkisz-Orzechowska, E., & Szymańska, E.
(2022). Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies. Molecules, 27(3), 875.
https://doi.org/10.3390/molecules27030875